ROYCE & ASSOCIATES LP - JOUNCE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$18,000
+63.6%
2,699
+95.9%
0.00%
Q2 2018$11,000
+57.1%
1,378
+134.4%
0.00%
Q4 2017$7,000
-12.5%
588
+16.2%
0.00%
Q3 2017$8,0005060.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP II, LLC 9,200,349$64,402,00044.86%
TRV GP III, LLC 3,048,780$21,342,0001.83%
SILVERARC CAPITAL MANAGEMENT, LLC 406,665$2,847,0001.65%
Sofinnova Investments, Inc. 925,280$6,477,0000.39%
Omega Fund Management, LLC 334,965$2,345,0000.35%
Yorktown Management & Research Co Inc 49,200$344,0000.31%
Woodline Partners LP 940,902$6,586,0000.18%
HUSSMAN STRATEGIC ADVISORS, INC. 51,000$357,0000.09%
HORIZON FINANCIAL SERVICES, LLC 12,005$84,0000.08%
Gyon Technologies Capital Management, LP 26,893$188,0000.06%
View complete list of JOUNCE THERAPEUTICS INC shareholders